Q-omics provides the consensus-scored LMLN2 profile across patient tissues and cancer cell-line models. Additionally, LMLN2 RNA expression shows 6,793 significant protein co-abundance associations, with the highest sampling consensus in CCRCC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for LMLN2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with LMLN2 in patient tissues and cancer cell lines. In patient samples, LMLN2 shows the broadest associations at the RNA and protein expression levels, with CCRCC recurring as the lineage with the largest associated feature set. In cancer cell lines, LMLN2 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BLOOD_Leukemia.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	6,793	CCRCC (2832)	view →
Function (mass-spec)	325	CCRCC (65)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	3,688	BLOOD_Leukemia (1521)	view →
Function (RNA)	776	BLOOD_Leukemia (235)	view →